A mutation update for the <i>FLNC</i> gene in myopathies and cardiomyopathiesJob A.J. Verdonschot, Han G. Brunner|Human Mutation|2020Cited by 178
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trialJohn G.F. Cleland, Theis Lange, Fozia Ahmed et al.|European Heart Journal|2020Cited by 143
Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart FailureJoão Pedro Ferreira, Faı̈ez Zannad, Job A.J. Verdonschot et al.|Circulation Heart Failure|2019Cited by 97
The burden of TTN variants in the genomic era: Analysis of 18,462 individuals from the Solve-RD consortium and general recommendationsMaria Francesca Di Feo, Leslie Matalonga Borrel, Ana Töpf et al.|Genetics in Medicine|2025Cited by 1